BAT3306
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BAT3306, covering 2024-10-30 to 2026-01-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants [Phase 1]